Evidence map›Paper›PMID 34704401›Full record

ArticleJournal of cachexia, sarcopenia and muscle2021

H19X-encoded miR-322(424)/miR-503 regulates muscle mass by targeting translation initiation factors.

Rui Liang, Xiaopeng Shen, Fan Wang, Xin Wang, Alex DesJarlais, Anam Syed, Raymond Saba, Zhi Tan, Fang Yu, Xuan Ji and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Epigenetics of Skeletal Muscle Atrophy.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Rui LiangDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Xiaopeng ShenDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Fan WangDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Xin WangDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Alex DesJarlaisDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Anam SyedDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Raymond SabaDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Zhi TanDepartment of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fang YuDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Xuan JiDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Shreesti ShresthaDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Yinghong RenDepartment of Oncology, Shangluo Central Hospital, Shangluo, Shaanxi Province, China.
Jin YangDepartment of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Yoonjung ParkDepartment of Health and Human Performance, University of Houston, Houston, TX, USA.
Robert J SchwartzDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Benjamin SoibamDepartment of Computer Science and Engineering Technology, University of Houston-Downtown, Houston, TX, USA.
Bradley K McConnellDepartment of Pharmacological & Pharmaceutical Sciences, University of Houston, Houston, TX, USA.
M David StewartDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Ashok KumarDepartment of Pharmacological & Pharmaceutical Sciences, University of Houston, Houston, TX, USA.
Yu LiuDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.ORCID 0000-0002-1282-4897
University of Houston · USShangluo Central Hospital · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNThe University of Texas MD Anderson Cancer Center · USUniversity of Houston - Downtown · US

Funding

TAK1/TRAF6 Signaling in Skeletal MuscleR01AR059810 · NIAMS · UNIVERSITY OF LOUISVILLE · PI KUMAR, ASHOK · 2011 to 2021
$4.0M
MYD88 Signaling in Mammalian Myoblast FusionR01AR068313 · NIAMS · UNIVERSITY OF LOUISVILLE · PI KUMAR, ASHOK · 2015 to 2019
$1.7M
Gravin Signalosome Protein Coordinates Cardiac Function via Adrenergic Receptor SignalingR15HL141963 · NHLBI · UNIVERSITY OF HOUSTON · PI MCCONNELL, BRADLEY K · 2019 to 2019
$459k
American Heart Association-American Stroke Association 11SDG5260033American Heart Association-American Stroke Association 16GRNT27760164NHLBI NIH HHS R15 HL141963NIAMS NIH HHS R01 AR059810NIAMS NIH HHS R01 AR068313NIH HHS AR059810NIH HHS AR068313
6 · The paper itself

Abstract

backgroundSkeletal muscle atrophy is a debilitating complication of many chronic diseases, disuse conditions, and ageing. Genome-wide gene expression analyses have identified that elevated levels of microRNAs encoded by the H19X locus are among the most significant changes in skeletal muscles in a wide scope of human cachectic conditions. We have previously reported that the H19X locus is important for the establishment of striated muscle fate during embryogenesis. However, the role of H19X-encoded microRNAs in regulating skeletal mass in adults is unknown.

methodsWe have created a transgenic mouse strain in which ectopic expression of miR-322/miR-503 is driven by the skeletal muscle-specific muscle creatine kinase promoter. We also used an H19X mutant mouse strain in which transcription from the locus is interrupted by a gene trap. Animal phenotypes were analysed by standard histological methods. Underlying mechanisms were explored by using transcriptome profiling and validated in the two animal models and cultured myotubes.

resultsOur results demonstrate that the levels of H19X microRNAs are inversely related to postnatal skeletal muscle growth. Targeted overexpression of miR-322/miR-503 impeded skeletal muscle growth. The weight of gastrocnemius muscles of transgenic mice was only 54.5% of the counterparts of wild-type littermates. By contrast, interruption of transcription from the H19X locus stimulates postnatal muscle growth by 14.4-14.9% and attenuates the loss of skeletal muscle mass in response to starvation by 12.8-21.0%. Impeded muscle growth was not caused by impaired IGF1/AKT/mTOR signalling or a hyperactive ubiquitin-proteasome system, instead accompanied by markedly dropped abundance of translation initiation factors in transgenic mice. miR-322/miR-503 directly targets eIF4E, eIF4G1, eIF4B, eIF2B5, and eIF3M.

conclusionsOur study illustrates a novel pathway wherein H19X microRNAs regulate skeletal muscle growth and atrophy through regulating the abundance of translation initiation factors, thereby protein synthesis. The study highlights how translation initiation factors lie at the crux of multiple signalling pathways that control skeletal muscle mass.

Indexed as

MicroRNAsMuscular AtrophyAnimalsMiceMuscle Fibers, SkeletalMuscle, SkeletalPeptide Initiation FactorsMicroRNAsMIRN322 microRNA, mousePeptide Initiation FactorsAtromiRH19XMicroRNAsmiR-322miR-424miR-503miR-542Protein synthesisSkeletal muscle atrophyTranslation initiation

Identifiers

PMID34704401
PMCPMC8718088
OpenAlexW3208685543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.